Notice of Effectiveness (effect)
14 Novembro 2022 - 8:13AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | November 10,
2022 |
---|
Form: | S-1 |
---|
CIK: | 0001815974 |
---|
Company Name: | Anebulo Pharmaceuticals, Inc. |
---|
File Number: | 333-268113 |
---|
Anebulo Pharmaceuticals (NASDAQ:ANEB)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Anebulo Pharmaceuticals (NASDAQ:ANEB)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025